Zobrazeno 1 - 10
of 194
pro vyhledávání: '"Massimiliano Calabrese"'
Autor:
Stefano Ziccardi, Helen Genova, Elisa Colato, Maddalena Guandalini, Agnese Tamanti, Massimiliano Calabrese
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 7, Pp 1798-1808 (2024)
Abstract Objective Cognitive and affective symptoms in multiple sclerosis (MS) can be independently impaired and have different pathways of progression. Cognitive alterations have been described since the earliest MS stages; by contrast, the social c
Externí odkaz:
https://doaj.org/article/9dcecb28de014e45b62cac1cecd7ac71
Autor:
Valentina Visani, Francesca B. Pizzini, Valerio Natale, Agnese Tamanti, Mariagiulia Anglani, Alessandra Bertoldo, Massimiliano Calabrese, Marco Castellaro
Publikováno v:
European Radiology Experimental, Vol 8, Iss 1, Pp 1-10 (2024)
Abstract We compared choroid plexus (ChP) manual segmentation on non-contrast-enhanced (non-CE) sequences and reference standard CE T1- weighted (T1w) sequences in 61 multiple sclerosis patients prospectively included. ChP was separately segmented on
Externí odkaz:
https://doaj.org/article/c39a1c7d92ec4d9da12de6897b6ac946
Autor:
Damiano Marastoni, Matteo Foschi, Chiara Eccher, Francesco Crescenzo, Valentina Mazziotti, Agnese Tamanti, Albulena Bajrami, Valentina Camera, Stefano Ziccardi, Maddalena Guandalini, Francesca Bosello, Daniela Anni, Federica Virla, Ermanna Turano, Michele Romoli, Raffaella Mariotti, Francesca Benedetta Pizzini, Bruno Bonetti, Massimiliano Calabrese
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundCladribine has been introduced as a high-efficacy drug for treating relapsing-remitting multiple sclerosis (RRMS). Initial cohort studies showed early disease activity in the first year after drug initiation. Biomarkers that can predict ear
Externí odkaz:
https://doaj.org/article/9d9749d94e1345dbaab41d85453fce9a
Autor:
Alberto Gajofatto, Nicolò Cardobi, Francesca Gobbin, Massimiliano Calabrese, Marco Turatti, Maria Donata Benedetti
Publikováno v:
BMC Neurology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Nabiximols (Sativex®) is a cannabinoid approved for multiple sclerosis (MS)-related spasticity. Its mechanism of action is partially understood, and efficacy is variable. Objective To conduct an exploratory analysis of brain netw
Externí odkaz:
https://doaj.org/article/1ddb7b989ded4cc9ad61d42fa62670f5
Autor:
Elena Andretta, Enrico Finazzi Agrò, Massimiliano Calabrese, Luca Orecchia, Antonietta Furlan, Cristina Zuliani
Publikováno v:
Therapeutic Advances in Urology, Vol 14 (2022)
Background: Antimuscarinics (AMs) represent the mainstay of treatment for storage lower urinary tract symptoms (LUTS) but few data are available on their impact in multiple sclerosis (MS) patients. Objective: To assess effectiveness and tolerability
Externí odkaz:
https://doaj.org/article/4a6cfbd27c4c431cb41cca3d90c1f707
Autor:
Damiano Marastoni, Anna I. Pisani, Gianmarco Schiavi, Valentina Mazziotti, Marco Castellaro, Agnese Tamanti, Francesca Bosello, Francesco Crescenzo, Giuseppe K. Ricciardi, Stefania Montemezzi, Francesca B. Pizzini, Massimiliano Calabrese
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 15 (2022)
Background: Disease activity in the first years after a diagnosis of relapsing-remitting multiple sclerosis (RRMS) is a negative prognostic factor for long-term disability. Markers of both clinical and radiological responses to disease-modifying ther
Externí odkaz:
https://doaj.org/article/eddcc01d735d439ca9d476f95f55ca08
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis
Autor:
Roberta Magliozzi, Marco Pitteri, Stefano Ziccardi, Anna Isabella Pisani, Luigi Montibeller, Damiano Marastoni, Stefania Rossi, Valentina Mazziotti, Maddalena Guandalini, Caterina Dapor, Gianmarco Schiavi, Agnese Tamanti, Richard Nicholas, Richard Reynolds, Massimiliano Calabrese
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 3, Pp 534-547 (2021)
Abstract Introduction and methods In order to verify whether parvalbumin (PVALB), a protein specifically expressed by GABAergic interneurons, could be a MS‐specific marker of grey matter neurodegeneration, we performed neuropathology/molecular anal
Externí odkaz:
https://doaj.org/article/aa42246214c944089619483f200d1494
Autor:
Francesco Pezzini, Annalisa Pisani, Valentina Mazziotti, Damiano Marastoni, Agnese Tamanti, Edilio Borroni, Stefano Magon, Bastian Zinnhardt, Roberta Magliozzi, Massimiliano Calabrese
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 4, p 3768 (2023)
Intrathecal inflammation plays a key role in the pathogenesis of multiple sclerosis (MS). To better elucidate its relationship with peripheral inflammation, we investigated the correlation between cerebrospinal fluid (CSF) and serum levels of 61 infl
Externí odkaz:
https://doaj.org/article/b88461ed63c54cd792db09ab7f1bfc14
Autor:
Roberta Magliozzi, Anna Pedrinolla, Stefania Rossi, Anna Maria Stabile, Elisa Danese, Giuseppe Lippi, Federico Schena, Massimiliano Calabrese, Massimo Venturelli Venturelli
Publikováno v:
Biomolecules, Vol 12, Iss 12, p 1867 (2022)
Absent or reduced physical activity and spontaneous movement over days, weeks, or even years may lead to problems in almost every major organ/system in the human body. In this study, we investigated whether the dysregulation and alteration of plasma
Externí odkaz:
https://doaj.org/article/aec74bcb28cf4866aa83cff18c7bd69c
Autor:
Stefano Ziccardi, Francesca Benedetta Pizzini, Maddalena Guandalini, Agnese Tamanti, Cecilia Cristofori, Massimiliano Calabrese
Publikováno v:
Bioengineering, Vol 10, Iss 1, p 41 (2022)
In multiple sclerosis (MS), the transition from relapsing-remitting to the secondary-progressive phase is characterized by a progression independent of relapse activity (PIRA), resulting in physical disability accumulation and invisible symptoms, i.e
Externí odkaz:
https://doaj.org/article/23217359a76c4f03a37f99bb10546f9e